EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Organs-on-Chips in Drug Development: Engineering Foundations, Artificial Intelligence, and Clinical Translation

Nilanjan Roy, Luca Cucullo iD

Biosensors · 11.03.2026 · 16 (3) · 155

DOI: 10.3390/bios16030155 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biosensors, online erschienen am 11.03.2026. Verfasst von Nilanjan Roy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Sciences, University of Wisconsin-Madison, 1210 West Dayton Street, Madison, WI 53706, USA. Hauptthemen laut MEDLINE: Artificial Intelligence, Lab-On-A-Chip Devices, Drug Development, Biosensing Techniques. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Organ-on-a-chip (OoC) technologies, also termed microphysiological systems (MPSs), integrate microfluidics, engineered biomaterials, human-derived cells, and on-chip biosensing to model human physiology in microscale devices that deliver quantitative, time-resolved readouts. This review surveys the 2010–2025 literature, emphasizing how sensing, standardized sampling, and analytics enable clinical concordance and fit-for-purpose regulatory use. We synthesize advances in (i) materials, fabrication, and microfluidic design; (ii) organ- and disease-focused case studies; and (iii) translational benchmarks that align chip outputs with clinical pharmacokinetics, toxicology, and biomarker datasets. Across organ systems, platforms increasingly incorporate vascularization, immune components, and organoid hybrids, paired with real-time measurements of barrier integrity, metabolism, electrophysiology, and secreted biomarkers using impedance (TEER), electrochemical, and optical modalities. Representative benchmarking studies report cardiac OoCs achieving AUROC ≥ 0.85 for torsadogenic risk classification, and renal chips improving prediction of transporter-mediated clearance relative to conventional in vitro assays. We summarize validation approaches and regulatory developments relevant to new approach methodologies, including the FDA Modernization Act 2.0, and discuss how AI and multi-omics can automate signal and image analysis, harmonize cross-platform datasets, and support digital-twin workflows that couple OoC measurements to in silico models. Overall, biosensor-enabled OoCs are progressing toward quantitatively benchmarked platforms for safety pharmacology, ADME/PK–PD, and precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceLab-On-A-Chip DevicesDrug DevelopmentBiosensing TechniquesHumansMicrophysiological SystemsMicrofluidicsTranslational Research, Biomedical

Stichwörter der Autor:innen

artificial intelligencebiosensorsmicrofluidicsmicrophysiological systemsmulti-omicsorgan-on-a-chipprecision medicinevalidation

Autor:innen und Institutionen

  • Department of Computer Sciences, University of Wisconsin-Madison, 1210 West Dayton Street, Madison, WI 53706, USA.
  • Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, 586 Pioneer Dr, Rochester, MI 48309, USA.

ORCID-Profile: Luca Cucullo

Förderung

  • NINDS NIH HHS
  • NIH

Zitieren

APA

Roy, N., & Cucullo, L. (2026). Organs-on-Chips in Drug Development: Engineering Foundations, Artificial Intelligence, and Clinical Translation. Biosensors, 16(3), 155. https://doi.org/10.3390/bios16030155

Vancouver

Roy N, Cucullo L. Organs-on-Chips in Drug Development: Engineering Foundations, Artificial Intelligence, and Clinical Translation. Biosensors. 2026;16(3):155. doi:10.3390/bios16030155

BibTeX
@article{Roy2026,
  author = {Roy, Nilanjan and Cucullo, Luca},
  title = {Organs-on-Chips in Drug Development: Engineering Foundations, Artificial Intelligence, and Clinical Translation},
  journal = {Biosensors},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {155},
  doi = {10.3390/bios16030155}
}
Kostenlos starten →